In addition, there is some evidence that PD-1/PD-L1 interaction is key to the maintenance of Treg cells [23] and thus blockade of this pathway may boost anti-tumor immunity in the tumor micro environment by affecting different cell types. Here, PDCD1 is linked to neoplasm.